Extracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up.

Thumbnail
URI
http://hdl.handle.net/11287/595884
Author
Taylor, James M.
Dunkerley, Sarah
Silver, David A.
Redfern, Andrew
Talbot, Nick J.
Sharpe, Ian T.
Guyver, Paul M.
Date
2016-03
Journal
Foot (Edinburgh, Scotland)
Type
Journal Article
Publisher
Elsevier
DOI
10.1016/j.foot.2015.08.007
Rights
Archived with thanks to Foot (Edinburgh, Scotland)
Metadata
Show full item record
Abstract
Achilles tendinopathy (AT) represents a triad of tendon pain, swelling and impaired performance. Extracorporeal shockwave therapy (ESWT) has been endorsed by the National Institute for Health and Care Excellence (NICE) for refractory AT. This audit investigates the long-term outcomes of patients treated with ESWT for refractory AT.
Citation
Extracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up. 2016, 26:23-29 Foot (Edinb)
Publisher URL
http://www.sciencedirect.com/science/article/pii/S095825921500084X
Collections